carcerand

carcerand. A carcerand is a type of synthetic, three-dimensional macrocyclic compound with an enclosed, rigid cavity that can permanently or semi-permanently entrap smaller guest molecules. These structures are a specialized class of host–guest complexes and are closely related to, but distinct from, hemicarcerands. The defining feature is the creation of an inner space from which the guest cannot escape without breaking covalent bonds in the host framework, leading to the concept of molecular incarceration.

Definition and structure

The structural core of a carcerand is typically formed by linking two cavitand bowls through multiple bridging groups, creating a sealed molecular capsule. This architecture is often based on calixarene or resorcinarene scaffolds that are functionalized and then coupled. The resulting cage compound possesses a constricted portal or opening that is smaller than the kinetic diameter of the encapsulated species. The rigidity of the framework, enforced by the covalent bridges, is crucial for maintaining permanent entrapment, distinguishing it from more flexible supramolecular assemblies like those formed by cucurbituril or cyclodextrin.

Synthesis and host-guest chemistry

Synthesis generally involves a final macrocyclization step, such as a Williamson ether synthesis or amide coupling, to connect the cavitand hemispheres in the presence of a suitable template molecule. This template synthesis is critical, as the guest aids in directing the formation of the cage around itself. Once formed, the guest is held in a solvent-free environment, isolated from the bulk solution. The release of the guest, or "escape kinetics," is immeasurably slow at ambient conditions, requiring harsh chemical treatment like hydrolysis or thermolysis to break the host's covalent bonds, a process studied using techniques like nuclear magnetic resonance spectroscopy.

Types and derivatives

The primary classification distinguishes between carcerands and hemicarcerands, the latter having larger openings that allow guest exchange under certain conditions. Variations include heterocarcerands incorporating different heteroatoms like nitrogen or sulfur into the bridge structures. Researchers like Donald J. Cram, who coined the term, also developed cryptophane-inspired systems. Modifications to the bridging units or the cavitand precursors, such as using pyrogallol instead of resorcinol, lead to carcerands with altered cavity sizes and binding affinities, enabling the study of novel isomers and reaction intermediates in isolation.

Applications and research

These compounds serve as molecular containers for stabilizing highly reactive intermediates, such as cyclopentadienone or aryne species, allowing their characterization by X-ray crystallography and spectroscopy. They are investigated as unique nanoreactors where incarcerated guests undergo reactions different from those in bulk solvent, potentially useful for catalysis or molecular electronics. Research groups, including those of Julius Rebek Jr., explore their use in chiral recognition and the isolation of isotopes. Their potential in drug delivery is limited by irreversibility but inspires work on stimuli-responsive hemicarcerands.

Historical development

The conceptual foundation was laid by Charles J. Pedersen's discovery of crown ethers and Jean-Marie Lehn's work on cryptands, which established host–guest chemistry. The term "carcerand" was first introduced by Donald J. Cram and his team at the University of California, Los Angeles in the 1980s, following their extensive research on spherands and complex molecular recognition. This work was recognized as part of Cram's contributions to supramolecular chemistry, for which he shared the Nobel Prize in Chemistry in 1987 with Lehn and Pedersen. Subsequent advancements by researchers like Ronald Breslow and Fraser Stoddart further expanded the field of mechanically interlocked molecules and complex host systems.